# Myrlene Sanon Aigbogun

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/myrlene-sanon-aigbogun/

## Facts

| Field | Value |
| --- | --- |
| Citations | 1,170 |
| Field | Dementia and Cognitive Impairment Research |
| h-index | 15 |
| i10-index | 19 |
| Last Known Institution | Johnson & Johnson (United States) |
| OpenAlex ID | https://openalex.org/A5058990884 |
| ORCID iD | 0000-0003-4027-1254 |
| Works | 27 |

## Researcher papers

- [The Economic Burden of Schizophrenia in the United States in 2013](https://scholariq.org/papers/the-economic-burden-of-schizophrenia-in-the-united-states-in-2013/)
- [Using electronic health records to estimate the prevalence of agitation in Alzheimer disease/dementia](https://scholariq.org/papers/using-electronic-health-records-to-estimate-the-prevalence-of-agitation-in/)
- [Family and Caregiver Spillover Effects in Cost-Utility Analyses of Alzheimer’s Disease Interventions](https://scholariq.org/papers/family-and-caregiver-spillover-effects-in-cost-utility-analyses-of-alzheimer-s/)
- [Agitation in patients with dementia: a systematic review of epidemiology and association with severity and course](https://scholariq.org/papers/agitation-in-patients-with-dementia-a-systematic-review-of-epidemiology-and/)
- [Treatment patterns and burden of behavioral disturbances in patients with dementia in the United States: a claims database analysis](https://scholariq.org/papers/treatment-patterns-and-burden-of-behavioral-disturbances-in-patients-with/)
- [Impact of agitation in long‐term care residents with dementia in the United States](https://scholariq.org/papers/impact-of-agitation-in-long-term-care-residents-with-dementia-in-the-united/)
- [Agitation in Dementia: Real-World Impact and Burden on Patients and the Healthcare System](https://scholariq.org/papers/agitation-in-dementia-real-world-impact-and-burden-on-patients-and-the/)
- [The societal economic burden of autosomal dominant polycystic kidney disease in the United States](https://scholariq.org/papers/the-societal-economic-burden-of-autosomal-dominant-polycystic-kidney-disease-in/)
- [A Real-world Analysis of Treatment Patterns for Cholinesterase Inhibitors and Memantine among Newly-diagnosed Alzheimer’s Disease Patients](https://scholariq.org/papers/a-real-world-analysis-of-treatment-patterns-for-cholinesterase-inhibitors-and/)
- [Institutionalization risk and costs associated with agitation in Alzheimer's disease](https://scholariq.org/papers/institutionalization-risk-and-costs-associated-with-agitation-in-alzheimer-s/)
- [Regional variations in prevalence and severity of autosomal dominant polycystic kidney disease in the United States](https://scholariq.org/papers/regional-variations-in-prevalence-and-severity-of-autosomal-dominant-polycystic/)
- [Disconnect in Assessments of Autosomal Dominant Polycystic Kidney Disease Burden Between Patients and Physicians: A Survey Study](https://scholariq.org/papers/disconnect-in-assessments-of-autosomal-dominant-polycystic-kidney-disease-burden/)

## Researcher topics

- [Dementia and Cognitive Impairment Research](https://scholariq.org/topics/dementia-and-cognitive-impairment-research/)
- [Healthcare Decision-Making and Restraints](https://scholariq.org/topics/healthcare-decision-making-and-restraints/)
- [Intensive Care Unit Cognitive Disorders](https://scholariq.org/topics/intensive-care-unit-cognitive-disorders/)
- [Health Systems, Economic Evaluations, Quality of Life](https://scholariq.org/topics/health-systems-economic-evaluations-quality-of-life/)
- [Genetic and Kidney Cyst Diseases](https://scholariq.org/topics/genetic-and-kidney-cyst-diseases/)

## Researcher university

- [Johnson & Johnson (United States)](https://scholariq.org/institutions/johnson-and-johnson-united-states/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.